BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19196533)

  • 1. Rapid and complete resolution of ascites and hydrothorax due to nephrotic syndrome caused by renal amyloidosis in a patient with juvenile chronic arthritis treated with adalimumab.
    Nowak B; Jeka S; Wiland P; Szechiński J
    Joint Bone Spine; 2009 Mar; 76(2):217-9. PubMed ID: 19196533
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiences on the use of biological drugs in psoriatic arthritis-associated amyloidosis.
    Immonen K; Kauppi M; Hakala M
    Scand J Rheumatol; 2011 May; 40(3):236-8. PubMed ID: 21231814
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of chronic tophaceous gout with infliximab (Remicade).
    Fiehn C; Zeier M
    Rheumatol Int; 2006 Jan; 26(3):274-6. PubMed ID: 15933855
    [No Abstract]   [Full Text] [Related]  

  • 4. When should we use TNF antagonists in children with rheumatic disease?
    Quartier P
    Joint Bone Spine; 2007 Jan; 74(1):1-3. PubMed ID: 17174585
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab.
    Kuroda T; Otaki Y; Sato H; Fujimura T; Nakatsue T; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Rheumatol Int; 2008 Sep; 28(11):1155-9. PubMed ID: 18496698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab therapy in nephrotic syndrome due to AH amyloidosis.
    Katoh N; Matsuda M; Miyazaki D; Gono T; Yazaki M; Ikeda S
    Amyloid; 2009; 16(3):178-80. PubMed ID: 19590993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Remission of Nephrotic Syndrome Without Resolution of Amyloid Deposit After Anti-Tumor Necrosis Factor α Therapy in a Patient With Ankylosing Spondylitis.
    Lee YH; Kim EY; Jeong DW; Kim YG; Lee SH; Song R; Yang HI; Lim SJ; Moon JY; Lee SH
    J Clin Rheumatol; 2016 Mar; 22(2):86-8. PubMed ID: 26906302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trials reveal promising options for treating juvenile rheumatoid arthritis.
    Hampton T
    JAMA; 2008 Jan; 299(1):27-8. PubMed ID: 18167400
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy.
    Han SA; Yoon YM; Lee WS; Kim YS; Shin BC; Chung JH; Kim HL
    Korean J Intern Med; 2016 May; 31(3):601-4. PubMed ID: 26947026
    [No Abstract]   [Full Text] [Related]  

  • 10. [Case report; a case of rheumatoid arthritis with renal amyloidosis and nephrotic syndrome effectively treated with tocilizumab].
    Hasegawa S; Sato A; Iesato K; Matsuda Y
    Nihon Naika Gakkai Zasshi; 2011 Jan; 100(1):185-7. PubMed ID: 21387652
    [No Abstract]   [Full Text] [Related]  

  • 11. Complete reversal of nephrotic syndrome secondary to amyloidosis with use of infliximab in a patient with inflammatory bowel disease and ankylosing spondylitis.
    Akdoğan MF; Gücün M; Denizli N; Güney M; Akdag I; Ozcan TB; Duranay M
    Ren Fail; 2011; 33(5):531-3. PubMed ID: 21574898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of anorexia nervosa with TNF-α down-regulating agents.
    Bou Khalil R; de Muylder O; Hebborn FL
    Eat Weight Disord; 2011 Dec; 16(4):e300. PubMed ID: 22526138
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoimmune aspects of treatment with TNF-alpha inhibitors].
    Kolarz B; Targońska-Stepniak B; Darmochwał-Kolarz D; Majdan M
    Postepy Hig Med Dosw (Online); 2007 Aug; 61():478-84. PubMed ID: 17786135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab in juvenile rheumatoid arthritis.
    de Vries MK; van der Horst-Bruinsma IE; Wolbink GJ
    N Engl J Med; 2008 Dec; 359(23):2496; author reply 2496-7. PubMed ID: 19065700
    [No Abstract]   [Full Text] [Related]  

  • 15. Juvenile idiopathic arthritis: current and future treatment options.
    Martini G; Zulian F
    Expert Opin Pharmacother; 2006 Mar; 7(4):387-99. PubMed ID: 16503811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab treatment for nephrotic syndrome due to amyloidosis in Behcet's disease.
    Redondo-Pachón MD; Enríquez R; Sirvent AE; Andrada E; Noguera-Pons R; Millán I; Amorós F
    Ren Fail; 2013; 35(4):547-50. PubMed ID: 23472940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranous nephropathy in rheumatoid arthritis: a case report.
    Maruotti N; Corrado A; Gaudio A; Cantatore FP
    Clin Exp Rheumatol; 2009; 27(5):840-2. PubMed ID: 19917171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab in juvenile rheumatoid arthritis.
    Taddio A; Marchetti F
    N Engl J Med; 2008 Dec; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness and safety of biological therapy with adalimumab].
    Fehér J; Lengyel G
    Orv Hetil; 2009 Jun; 150(26):1215-22. PubMed ID: 19546078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis.
    Barber J; Sheeran T; Mulherin D
    Ann Rheum Dis; 2003 May; 62(5):490-1. PubMed ID: 12695170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.